InvestorsHub Logo
Followers 3
Posts 74
Boards Moderated 0
Alias Born 08/23/2010

Re: None

Monday, 02/22/2016 8:32:29 AM

Monday, February 22, 2016 8:32:29 AM

Post# of 12450
Is this new?

Alzheimer’s disease

INT0043 is a unique repurposing opportunity for the treatment of Alzheimer ’s disease. IntelGenx is developing a film product based on the VersaFilm™ proprietary thin film technology and using an already FDA approved drug that has demonstrated potential for the treatment of Alzheimer ’s disease. IntelGenx is currently looking for a partnership or alliance opportunity to complete development and commercialize INT0043.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News